NRA-0562
NRA‑0562 is a dopamine antagonist with high affinities for dopamine D1/D2/D3/D4, 5‑HT2A and α1‑adrenoceptors. NRA-0562 dose‑dependently reverses induced suppression of firing activity in rat A9 and A10 midbrain dopamine neurons, with preferential potency at A10 neurons (ED50 = 0.3 mg/kg). NRA-0562 elevates Fos-like immunoreactivity in rat nucleus accumbens and dorsolateral striatum. NRA-0562 can be used for preclinical research on schizophrenia..
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- CAS. Nr.: 244276-65-1
- Formel: C25H24F2N4OS
- Molecular Weight:466.55
-
Speicherung:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biologische Aktivität
-
Chemical Information
- Reinheit & Dokumentation
- Verweise
-
Help & FAQs
Alle Dopamine Receptor Isoform-spezifische Produkte anzeigen
MoreAlle 5-HT Receptor Isoform-spezifische Produkte anzeigen
MoreAlle Adrenergic Receptor Isoform-spezifische Produkte anzeigen
More
Biologische Aktivität
|
Human D1 Receptor 7.09 nM (Ki) |
Human D2 Receptor 2.49 nM (Ki) |
Human D3 Receptor 3.48 nM (Ki) |
Human D4 Receptor 1.79 nM (Ki) |
α1-adrenergic receptor |
5-HT2A Receptor |
NRA-0562 exhibits high binding affinity for human cloned dopamine D1, D2, D3, and D4 receptors, with the highest affinity for D4 receptors (Ki = 1.79 nM) and lowest for D1 receptors (Ki = 7.09 nM)[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
NRA-0562 (1-30 mg/kg; i.p.) dose-dependently increases Fos-like immunoreactivity in the rat nucleus accumbens and dorsolateral striatum, with a positive atypical index consistent with atypical antipsychotic activity[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Wistar (male, 300-400 g, electrophysiological studies, methamphetamine-induced dopamine neuron inhibition model)[1]
-
Dosage:0.1 ; 0.2 ; 0.7 ;1 mg/kg
-
Administration:i.v.; sequentially every 2-3 minutes
-
Result:Reversed methamphetamine-induced inhibition of A9 and A10 dopamine neurons dose-dependently and significantly.
Achieved ED50 values of 0.3 mg/kg (A10) and 0.9 mg/kg (A9) for reversing dopamine neuron inhibition.
Showed no apparent effect on baseline firing rates of A9 or A10 dopamine neurons at 0.1-1 mg/kg.
-
Animal Model:Wistar (male, 280-320 g, immunohistochemical studies)[1]
-
Dosage:1 mg/kg; 3 mg/kg; 10 mg/kg; 30 mg/kg
-
Administration:i.p.
-
Result:Increased Fos-like positive nuclei counts in the nucleus accumbens and dorsolateral striatum dose-dependently and significantly at all tested doses.
Chemical Information
-
CAS. Nr. 244276-65-1
-
Molecular Weight 466.55
-
Formel C25H24F2N4OS
-
SMILES
O=C(C1=NC(C2=CC=C(C=C2)F)=C(CCN3CCC(CC3)C4=CNC5=C4C=CC(F)=C5)S1)N
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Please store the product under the recommended conditions in the Certificate of Analysis.
Reinheit & Dokumentation
Verweise
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)
NRA-0562 Related Classifications
HY-182504 Related Classifications
Powered by Bioz